Pharmaceutical Business review

Edgeline Holdings to become Oncolin Therapeutics

This decision comes after its recent acquisition of Intertech Bio which has propelled the company into the multi-billion dollar biotechnology industry through the addition of significant partnerships and the hiring of key personnel. The company will immediately suspend its other business that is not associated with biotechnology.

Exit mobile version